CTX vs. META, LABS, VM, WLLW, NRTH, MRV, MPH, FLWR, KHRN, and AH
Should you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Meta Growth (META), MediPharm Labs (LABS), Voyageur Pharmaceuticals (VM), Willow Biosciences (WLLW), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), Medicure (MPH), Flowr (FLWR), Khiron Life Sciences (KHRN), and Aleafia Health (AH). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Crescita Therapeutics vs. Its Competitors
Meta Growth (CVE:META) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.
Crescita Therapeutics has lower revenue, but higher earnings than Meta Growth. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.
In the previous week, Meta Growth had 5 more articles in the media than Crescita Therapeutics. MarketBeat recorded 5 mentions for Meta Growth and 0 mentions for Crescita Therapeutics. Meta Growth's average media sentiment score of 0.31 beat Crescita Therapeutics' score of 0.00 indicating that Meta Growth is being referred to more favorably in the media.
0.9% of Crescita Therapeutics shares are held by institutional investors. 10.9% of Crescita Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Meta Growth has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -15.73%. Meta Growth's return on equity of 0.00% beat Crescita Therapeutics' return on equity.
Summary
Meta Growth beats Crescita Therapeutics on 8 of the 12 factors compared between the two stocks.
Get Crescita Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crescita Therapeutics Competitors List
Related Companies and Tools
This page (TSE:CTX) was last updated on 10/10/2025 by MarketBeat.com Staff
